160 related articles for article (PubMed ID: 24162837)
1. Production, quality control, biodistribution assessment and preliminary dose evaluation of (177)Lu-PDTMP as a possible bone palliative agent.
Yousefnia H; Jalilian AR; Zolghadri S; Ghannadi-Maragheh M
Nucl Med Commun; 2014 Jan; 35(1):99-107. PubMed ID: 24162837
[TBL] [Abstract][Full Text] [Related]
2. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
3. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
4. Preparation, quality control and biodistribution assessment of ¹⁵³Sm-BPAMD as a novel agent for bone pain palliation therapy.
Rabie A; Enayati R; Yousefnia H; Jalilian AR; Shamsaei M; Zolghadri S; Bahrami-Samani A; Hosntalab M
Ann Nucl Med; 2015 Dec; 29(10):870-6. PubMed ID: 26260999
[TBL] [Abstract][Full Text] [Related]
5. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
[TBL] [Abstract][Full Text] [Related]
6. Preliminary dosimetry of (166)Ho-propylene di-amino tetra (methy1enephosphonicacid) for human based on biodistribution data in rats.
Zolghadri S; Yousefnia H; Jalilian AR; Shiri-Yekta Z; Maragheh MG
J Cancer Res Ther; 2015; 11(4):862-7. PubMed ID: 26881532
[TBL] [Abstract][Full Text] [Related]
7. Production, Quality Control and Biological Evaluation of (166)Ho-PDTMP as a Possible Bone Palliation Agent.
Zolghadri S; Jalilian AR; Naseri Z; Yousefnia H; Bahrami-Samani A; Ghannadi-Maragheh M; Afarideh H
Iran J Basic Med Sci; 2013 May; 16(5):719-25. PubMed ID: 23826495
[TBL] [Abstract][Full Text] [Related]
8. Human Absorbed Dose Evaluation of [177Lu]Lu-IBA as a Bone Palliative Candidate.
Ranjbar H; Pourhabib Z
Nuklearmedizin; 2021 Oct; 60(5):375-380. PubMed ID: 34102691
[TBL] [Abstract][Full Text] [Related]
9. Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent.
Zolghadri S; Jalilian AR; Yousefnia H; Bahrami-Samani A; Ghannadi-Maragheh M
World J Nucl Med; 2014 Jan; 13(1):28-33. PubMed ID: 25191109
[TBL] [Abstract][Full Text] [Related]
10. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
[TBL] [Abstract][Full Text] [Related]
11. Production, quality control, and determination of human absorbed dose of no carrier added
Salek N; Mehrabi M; Shirvani Arani S; Bahrami Samani A; Erfani M; Vosoghi S; Ghannadi Maragheh M; Shamsaei M
J Labelled Comp Radiopharm; 2017 Jan; 60(1):20-29. PubMed ID: 27862203
[TBL] [Abstract][Full Text] [Related]
12. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
[TBL] [Abstract][Full Text] [Related]
13. Production, biodistribution assessment and dosimetric evaluation of (177)Lu-TTHMP as an agent for bone pain palliation.
Zolghadri S; Yousefnia H; Jalilian AR; Ghannadi-Maragheh M
Asia Ocean J Nucl Med Biol; 2015; 3(1):35-42. PubMed ID: 27408879
[TBL] [Abstract][Full Text] [Related]
14. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
Konijnenberg MW; Bijster M; Krenning EP; De Jong M
J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
[TBL] [Abstract][Full Text] [Related]
15. Samarium-153-(4-[((bis (phosphonomethyl)) carbamoyl) methyl]-7,10-bis (carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl) acetic acid: A novel agent for bone pain palliation therapy.
Yousefnia H; Enayati R; Hosntalab M; Zolghadri S; Bahrami-Samani A
J Cancer Res Ther; 2016; 12(3):1117-1123. PubMed ID: 28054521
[TBL] [Abstract][Full Text] [Related]
16. Optimized Production and Biological Evaluation of
Tadayon N; Yousefnia H; Ramazani A; Zolghadri S; Alirezapour B; Jalilian AR; Afarideh H; Vaez-Tehrani M
J Med Imaging Radiat Sci; 2019 Mar; 50(1):142-148. PubMed ID: 30777236
[TBL] [Abstract][Full Text] [Related]
17. A "mix-and-use" approach for formulation of human clinical doses of
Chakraborty S; Vimalnath KV; Rajeswari A; Chakravarty R; Sarma HD; Radhakrishnan E; Kamaleshwaran K; Shinto AS; Dash A
J Labelled Comp Radiopharm; 2017 Jul; 60(9):410-419. PubMed ID: 28477391
[TBL] [Abstract][Full Text] [Related]
18. Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation.
Salek N; Shamsaei M; Ghannadi Maragheh M; Shirvani Arani S; Bahrami Samani A
J Appl Clin Med Phys; 2016 Nov; 17(6):128-139. PubMed ID: 27929488
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on the potential use of
Zakaly HMH; Mostafa MYA; Deryabina D; Zhukovsky M
Int J Radiat Biol; 2020 Jun; 96(6):779-789. PubMed ID: 32043915
[No Abstract] [Full Text] [Related]
20. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
